THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Novartis expects to grow more, but slower

Glass elevators and curving shapes in the atrium define Novartis's Cambridge building. Glass elevators and curving shapes in the atrium define Novartis's Cambridge building. (John Tlumacki/Globe Staff/File 2005)
By Todd Wallack
Globe Staff / October 20, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Six years after the Swiss drug giant Novartis AG built a major research center in Cambridge, the move is bearing fruit, corporate executives say. (Full article: 696 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass